Corbo, Junard S.
HRN: 23 44 03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2023
CEFTAZIDIME 1GM (VIAL)
08/07/2023
08/13/2023
IV
2 G
Q8
Pneumonia /sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes